Filing Flows › Bio Essence (BIOE) › Q2 2026 › vs Q1 2026
Bio Essence (BIOE) Q2 2026 vs Q1 2026 (quarter over quarter)
Bio Essence's revenue rose $294K (+59%) from $501K in Q1 2026 to $795K in Q2 2026. Gross margin 59.2% against 63.8% (-4.6 pts).
Bio Essence, Q2 2026: revenue $795K (+207% year over year), operating margin 35.1%, net earnings $270K, operating cash flow $60K. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 59.2% | 63.8% | -4.6 pts |
| Operating margin | 35.1% | 43.1% | -8.0 pts |
| Net margin | 34.0% | 41.0% | -7.0 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $795K | $501K | $294K | +59% |
| Gross profit | $470K | $319K | $151K | +47% |
| Cost of revenue | $324K | $181K | $143K | +79% |
| Operating profit | $279K | $216K | $63K | +29% |
| Operating expenses | $191K | $104K | $87K | +84% |
| Pre-tax earnings | $280K | $215K | $65K | +30% |
| Net earnings | $270K | $205K | $65K | +32% |
| Income tax | $10K | $10K | $1K | +6% |
| Operating cash sources | $374K | $205K | $168K | +82% |
| Depreciation & amortization | $104K | $59 | $104K | 1,756× |
| Working capital & other | $314K | $617K | −$303K | -49% |
| Operating cash flow | $60K | −$412K | $472K | — |
Questions
How much did Bio Essence's revenue grow quarter over quarter in Q2 2026?
Bio Essence's revenue rose $294K (+59%) from $501K in Q1 2026 to $795K in Q2 2026. Gross margin 59.2% against 63.8% (-4.6 pts).